Buckbee Kevin K 4
4 · AbbVie Inc. · Filed Feb 28, 2025
Insider Transaction Report
Form 4
AbbVie Inc.ABBV
Buckbee Kevin K
SVP, CONTROLLER
Transactions
- Exercise/Conversion
Common Stock, $0.01 par value
2025-02-26$105.92/sh+6,522$690,810→ 28,906 total - Exercise/Conversion
Option (Right to buy)
2025-02-26$93.50/sh−9,738$910,503→ 2,373 totalExercise: $93.50From: 2021-02-20Exp: 2030-02-19→ Common Stock (9,738 underlying) - Exercise/Conversion
Option (Right to buy)
2025-02-26$105.92/sh−6,522$690,810→ 2,794 totalExercise: $105.92From: 2022-02-18Exp: 2031-02-17→ Common Stock (6,522 underlying) - Exercise/Conversion
Common Stock, $0.01 par value
2025-02-26$93.50/sh+9,738$910,503→ 22,384 total - Sale
Common Stock, $0.01 par value
2025-02-26$203.40/sh−2,684$545,926→ 12,646 total - Sale
Common Stock, $0.01 par value
2025-02-26$203.41/sh−16,260$3,307,447→ 11,496 total
Footnotes (3)
- [F1]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.39 to $203.48, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The reporting person transferred 1,150 shares of common stock to his former spouse pursuant to a domestic relations order since his last ownership report and has ceased to be the beneficial owner of such shares.
- [F3]Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.